During the past decade, UMHAT Psych clin for gen psychiatry and addictions conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UMHAT Psych clin for gen psychiatry and addictions" are "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials). Many other conditions were trialed in "UMHAT Psych clin for gen psychiatry and addictions" in a lesser frequency.

Most popular intervention types in "UMHAT Psych clin for gen psychiatry and addictions" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pimavanserin" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT Psych clin for gen psychiatry and addictions" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UMHAT Psych clin for gen psychiatry and addictions". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UMHAT Psych clin for gen psychiatry and addictions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT Psych clin for gen psychiatry and addictions, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".